| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| GTO ID | GTC3255 |
| Trial ID | NCT05632380 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | C-CAR088 |
| Co-treatment | autologous stem cell transplantation |
| Generation | 2nd |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | ASCT in Combination With C-CAR088 for Treating Patients With Ultra High-risk Multiple Myeloma (MM) |
| Year | 2022 |
| Country | China |
| Company sponsor | Institute of Hematology & Blood Diseases Hospital |
| Other ID(s) | 0203-037 |
| Cohort 1 | |||||||||
|
|||||||||